Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1 clinical study titled A PHASE 1, ...

Photocure ASA (($PHCUF)) announced an update on their ongoing clinical study. The clinical study titled ‘Exploration of Novel AI-enabled Blue ...

Blood in urine, known as haematuria, can signal kidney cancer. This symptom, whether visible or microscopic, demands ...

According to reports circulating last week, the Government is set to kick into the long grass the proposal for a national ...

Pfizer and Japanese firm Astellas' drug Padcev, combined with Merck's Keytruda, lowered the risk of tumor recurrence, ...

The BladderPath trial indicates that mpMRI can expedite MIBC treatment and improve bladder cancer-specific survival compared to traditional TURBT. The study showed a significant improvement in BCSS ...

Presentation of data at ESMO Congress 2025 shows MRI scanning before usual diagnostic route sped up time to treatment ...

A HALF-HOUR scan could nearly halve bladder cancer deaths, a study suggests. Giving patients an MRI scan before the usual ...

Researchers in China combined findings from MRI scans with clinical features to create a new predictive model for nonmuscle-invasive bladder cancer recurrence.

The former PM is among those in favour of targeted screening for men most at risk, but some medical experts are sceptical.

Bladder cancer is one of the most common cancers worldwide. Men are around four times more likely to develop it than women, and smoking is the main known environmental risk factor. However, the ...